Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Thrombocytopenia × Tranexamic Acid × Clear all

Phase

Status

Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Myeloid 1 Classical hematology 1

Conditions

Neoplasms 2 Hemorrhage 2 Thrombocytopenia 1 Recurrence 1 Postoperative Hemorrhage 1 Myelodysplastic Syndromes 1 Melanoma 1 Leukemia, Myeloid, Acute 1 Hematologic Neoplasms 1 Colonic Neoplasms 1 Breast Neoplasms 1 Brain Neoplasms 1 Blood Loss, Surgical 1

Interventions

apixaban 1 Tranexamic Acid 1 Tinzaparin 1 Enoxaparin 1 Dalteparin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06599762 2025-09-17

MYELO-CAN:TXA

University of Manitoba

Phase 2 Recruiting

Classical hematologyMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Thrombocytopenia, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡